Literature DB >> 11357850

Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin.

M Viguier, L Guillevin, L Laroche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11357850     DOI： 10.1056/NEJM200105103441919

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 2.  Intravenous immunoglobulin therapy in vasculitis: speculation or evidence?

Authors:  Peer Malte Aries; Bernhard Hellmich; Wolfgang Ludwig Gross
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  High-dose intravenous immunoglobulin infusion in polyarteritis nodosa: report on one case and review of the literature.

Authors:  Yoshihide Asano; Hironobu Ihn; Takeo Maekawa; Takafumi Kadono; Kunihiko Tamaki
Journal:  Clin Rheumatol       Date:  2005-10-19       Impact factor: 2.980

4.  No evidence of parvovirus B19 in tissue samples from patients with polyarteritis nodosa and microscopic polyangiitis as assessed by the polymerase chain reaction.

Authors:  Z Sachetto; S C B Costa; P D Andrade; R A Conde; E M I Amstalden; A M Samara; S R M Fernandes
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

Review 5.  Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.

Authors:  Andreas Steinbrecher; Peter Berlit
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 6.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

7.  Parvovirus B19 Infection in Children With Arterial Ischemic Stroke.

Authors:  Heather J Fullerton; Jorge M Luna; Max Wintermark; Nancy K Hills; Rafal Tokarz; Ying Li; Carol Glaser; Gabrielle A DeVeber; W Ian Lipkin; Mitchell S V Elkind
Journal:  Stroke       Date:  2017-09-01       Impact factor: 7.914

8.  Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome.

Authors:  Timothée Lenglet; Julien Haroche; Aurélie Schnuriger; Thierry Maisonobe; Karine Viala; Yanne Michel; Farhat Chelbi; David Grabli; Paul Seror; Antoine Garbarg-Chenon; Zahir Amoura; Pierre Bouche
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 6.682

Review 9.  Neurological aspects of human parvovirus B19 infection: a systematic review.

Authors:  Faraj Barah; Sigrid Whiteside; Sonia Batista; Julie Morris
Journal:  Rev Med Virol       Date:  2014-01-24       Impact factor: 6.989

10.  Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.

Authors:  Marion Dollat; Benjamin Chaigne; Grégoire Cormier; Nathalie Costedoat-Chalumeau; François Lifermann; Alban Deroux; Emilie Berthoux; Emmanuelle Dernis; Thomas Sené; Gilles Blaison; Olivier Lambotte; Benjamin Terrier; Jérémie Sellam; Luc De Saint-Martin; Laurent Chiche; Nicolas Dupin; Luc Mouthon
Journal:  BMC Infect Dis       Date:  2018-07-04       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.